<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01925040</url>
  </required_header>
  <id_info>
    <org_study_id>HKG-DT-01/2011-SOCO-CLIN</org_study_id>
    <nct_id>NCT01925040</nct_id>
  </id_info>
  <brief_title>Comparison of 2 Different Resin Based Filling Materials in Posterior Teeth - a Multicenter Study</brief_title>
  <official_title>Clinical Investigation of a New Nanohybrid Resin Composite Venus Pearl in Class 2 Cavities- a Multi-center Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Heraeus Kulzer GmbH</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Heraeus Kulzer GmbH</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to compare the clinical performance of a new resin based filling&#xD;
      material to an established resin-based filling material in posterior teeth at 2 different&#xD;
      study centers.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The objective of this study is to compare the performance of the composite resin Venus Pearl&#xD;
      and a commercially available control composite material for the restoration of class&#xD;
      II-cavities. Primary endpoints of the study are a mean score for each patient calculated from&#xD;
      aesthetic, functional attribute and biological parameters. Secondary endpoints are the&#xD;
      evaluation of secondary caries, plaque accumulation and gingival reactions and the comparison&#xD;
      of the primary score at week 1, month 6, month 12 and month 24 after restoration. Beside&#xD;
      this, the single components of the three categories of the primary endpoints will be&#xD;
      compared. The study will be executed as a multi-center (Oregon Health &amp; Science University,&#xD;
      Portland, OR, USA and Medical School Hannover, Hannover, Germany), single-blinded and&#xD;
      randomized clinical investigation. 90 comparable cavities per study site will be treated (45&#xD;
      cavities for each material at each site).&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>June 2013</start_date>
  <primary_completion_date type="Anticipated">June 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Score</measure>
    <time_frame>2 years</time_frame>
    <description>The primary endpoint will be a mean score calculated as following: There are three aspects to be assessed: aesthetic, functional attribute and biological parameters.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">180</enrollment>
  <condition>Caries</condition>
  <condition>Unsatisfactory or Defective Restoration of Tooth</condition>
  <arm_group>
    <arm_group_label>Venus Pearl</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Placement of restoration using Venus Pearl in carious teeth or as a replacement of a defective previous restoration.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control resin-based filling material</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Placement of restoration using a control resin-based filling material in carious teeth or as a replacement of a defective previous restoration.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Placement of restoration</intervention_name>
    <description>Placement of restorations</description>
    <arm_group_label>Venus Pearl</arm_group_label>
    <arm_group_label>control resin-based filling material</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients should be 18 years and older.&#xD;
&#xD;
          -  Study teeth should have an interproximal (Class II) carious lesion or an existing&#xD;
             defective class II restoration requiring restorative therapy on premolars or molars.&#xD;
&#xD;
          -  The maximum cavity depth determined by the radiograph will be D2 (Tyas&#xD;
             classification).&#xD;
&#xD;
          -  The teeth included in the study need to have a proximal contact with the adjacent&#xD;
             tooth and be in occlusion with the opposing dentition.&#xD;
&#xD;
          -  The teeth included in the study should be vital with no signs of pulpal pathology.&#xD;
&#xD;
          -  Patients that report brushing regularly without severe gingival inflammation and/or&#xD;
             extensive caries.&#xD;
&#xD;
          -  Patients should have no allergies or systemic diseases which inhibit the treatment.&#xD;
&#xD;
          -  Patients should have voluntary participation and sign a written informed consent form.&#xD;
&#xD;
          -  Patients should be willing to participate in the recall/re-examination appointments.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Simultaneous participation in another study about dental restorative materials.&#xD;
&#xD;
          -  Written informed consent form not signed.&#xD;
&#xD;
          -  Nonvital pulp / periapical lesion.&#xD;
&#xD;
          -  Insufficient oral hygiene despite detailed instructions.&#xD;
&#xD;
          -  Pregnancy/ breast feeding before placement of the study restoration.&#xD;
&#xD;
          -  Minors.&#xD;
&#xD;
          -  Severe malocclusion/ malalignment/ traumatic occlusion/ bruxism.&#xD;
&#xD;
          -  Known allergy to any components present in any of the materials that are used for this&#xD;
             study.&#xD;
&#xD;
          -  Unclear mucosal alterations, e.g. oral lichenoid reactions/lesions.&#xD;
&#xD;
          -  Severe medical complications (organ transplants, cancer, immune-compromised, long-term&#xD;
             antibiotic or steroid therapy).&#xD;
&#xD;
          -  Infectious diseases such as HIV/Aids, Hepatitis, etc.&#xD;
&#xD;
          -  Application of bleaching products less than 14 days before placement of the&#xD;
             restoration.&#xD;
&#xD;
          -  Orthodontic treatment during the study.&#xD;
&#xD;
          -  Xerostomia.&#xD;
&#xD;
          -  Untreated periodontal diseases.&#xD;
&#xD;
          -  Rampant or extensive caries present.&#xD;
&#xD;
          -  Systemic diseases with potential oral manifestation.&#xD;
&#xD;
          -  Sufficient isolation according to the criteria of adhesive techniques not possible,&#xD;
             e.g. application of rubber dam.&#xD;
&#xD;
          -  Direct adhesive restoration not indicated.&#xD;
&#xD;
          -  Replacement of more than one cusp indicated.&#xD;
&#xD;
          -  Dental fears patients.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Werner Geurtsen, Prof. Dr.</last_name>
    <role>Study Chair</role>
    <affiliation>Hannover Medical School</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Gabriela Ibarra, DDS, MPH, MS</last_name>
    <role>Principal Investigator</role>
    <affiliation>Oregon Health and Science University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Werner Geurtsen, Prof. Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Medical School Hannover</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Oregon Health and Science University-School of Dentistry</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97239</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gabriela Ibarra, DDS, MPH, MS</last_name>
      <email>ibarrag@ohsu.edu</email>
    </contact>
    <investigator>
      <last_name>Gabriela Ibarra, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Medical School Hannover</name>
      <address>
        <city>Hannover</city>
        <zip>30625</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Werner Geurtsen, Prof. Dr.</last_name>
      <email>Geurtsen.Werner@mh-hannover.de</email>
    </contact>
    <investigator>
      <last_name>Werner Geurtsen, Prof.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2013</verification_date>
  <study_first_submitted>August 15, 2013</study_first_submitted>
  <study_first_submitted_qc>August 15, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 19, 2013</study_first_posted>
  <last_update_submitted>August 15, 2013</last_update_submitted>
  <last_update_submitted_qc>August 15, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 19, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

